Income Tax Expense (Benefit) in USD of CVS HEALTH Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
CVS HEALTH Corp quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • CVS HEALTH Corp Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $508M, a 1394% increase year-over-year.
  • CVS HEALTH Corp Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $2.48B, a 44.4% increase year-over-year.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2024 was $1.56B, a 44.3% decline from 2023.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2023 was $2.81B, a 85.9% increase from 2022.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2022 was $1.51B, a 40.8% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

CVS HEALTH Corp Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.48B $508M +$474M +1394% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $2.01B $634M +$65M +11.4% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $1.94B $835M +$379M +83.1% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $1.56B $503M -$155M -23.6% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2025
Q3 2024 $1.72B $34M -$720M -95.5% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $2.44B $569M -$87M -13.3% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $2.52B $456M -$281M -38.1% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $2.81B $658M -$160M -19.6% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2025
Q3 2023 $2.97B $754M +$1.8B 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $1.17B $656M -$434M -39.8% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $1.6B $737M +$91M +14.1% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $1.51B $818M +$518M +173% 01 Oct 2022 31 Dec 2022 10-K 12 Feb 2025
Q3 2022 $991M -$1.05B -$1.6B -287% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $2.59B $1.09B +$146M +15.5% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $2.45B $646M -$100M -13.4% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $2.55B $300M +$59M +24.5% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024
Q3 2021 $2.49B $558M -$29M -4.94% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $2.52B $944M -$30M -3.08% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $2.55B $746M -$21M -2.74% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $2.57B $241M -$349M -59.2% 01 Oct 2020 31 Dec 2020 8-K 25 May 2023
Q3 2020 $2.92B $587M -$17M -2.82% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $2.94B $974M +$314M +47.6% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $2.62B $767M +$255M +49.8% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $2.37B $590M +$66M +12.6% 01 Oct 2019 31 Dec 2019 10-K 09 Feb 2022
Q3 2019 $2.3B $604M +$95M +18.7% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 $2.21B $660M +$163M +32.8% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 $2.04B $512M +$40M +8.48% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $2B $524M +$1B 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021
Q3 2018 $1B $509M -$268M -34.5% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 $1.27B $497M -$269M -35.1% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $1.54B $472M -$100M -17.5% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019
Q4 2017 $1.64B -$478M -$1.52B -146% 01 Oct 2017 31 Dec 2017 10-K 18 Feb 2020
Q3 2017 $3.16B $777M -$144M -15.6% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 $3.31B $766M +$162M +26.8% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 $3.14B $572M -$174M -23.3% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $3.32B $1.05B +$94M +9.87% 01 Oct 2016 31 Dec 2016 8-K 08 Aug 2019
Q3 2016 $3.22B $921M +$88M +10.6% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 $3.14B $604M -$220M -26.7% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 $3.36B $746M -$31M -3.99% 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017
Q4 2015 $3.39B $952M +$84M +9.68% 01 Oct 2015 31 Dec 2015 10-K 14 Feb 2018
Q3 2015 $3.3B $833M +$209M +33.5% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 $3.09B $824M +$20M +2.49% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q1 2015 $3.07B $777M +$40M +5.43% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016
Q4 2014 $3.03B $868M +$52M +6.37% 01 Oct 2014 31 Dec 2014 10-K 09 Feb 2017
Q3 2014 $2.98B $624M -$153M -19.7% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015
Q2 2014 $3.13B $804M +$83M +11.5% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015
Q1 2014 $3.05B $737M +$123M +20% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015
Q4 2013 $2.93B $816M +$155M +23.4% 01 Oct 2013 31 Dec 2013 10-K 09 Feb 2016
Q3 2013 $2.77B $777M +$108M +16.1% 01 Jul 2013 30 Sep 2013 10-Q 04 Nov 2014
Q2 2013 $2.67B $721M +$111M +18.2% 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014
Q1 2013 $2.55B $614M +$118M +23.8% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014
Q4 2012 $2.44B $661M -$50M -7.03% 01 Oct 2012 31 Dec 2012 10-K 10 Feb 2015
Q3 2012 $2.49B $669M +$107M +19% 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013
Q2 2012 $2.38B $610M +$87M +16.6% 01 Apr 2012 30 Jun 2012 10-Q 06 Aug 2013
Q1 2012 $2.29B $496M +$34M +7.36% 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013
Q4 2011 $2.26B $711M +$112M +18.7% 01 Oct 2011 31 Dec 2011 10-K 11 Feb 2014
Q3 2011 $2.15B $562M +$36M +6.84% 01 Jul 2011 30 Sep 2011 10-Q 06 Nov 2012
Q2 2011 $2.11B $523M -$21M -3.86% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012
Q1 2011 $2.13B $462M -$48M -9.41% 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012
Q4 2010 $2.18B $599M 01 Oct 2010 31 Dec 2010 10-K 15 Feb 2013
Q3 2010 $526M 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011
Q2 2010 $544M 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011
Q1 2010 $510M 01 Jan 2010 31 Mar 2010 10-Q 05 May 2011

CVS HEALTH Corp Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.56B -$1.24B -44.3% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 $2.81B +$1.3B +85.9% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 $1.51B -$1.04B -40.8% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025
2021 $2.55B -$21M -0.82% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024
2020 $2.57B +$203M +8.58% 01 Jan 2020 31 Dec 2020 8-K 25 May 2023
2019 $2.37B +$364M +18.2% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022
2018 $2B +$365M +22.3% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $1.64B -$1.68B -50.6% 01 Jan 2017 31 Dec 2017 10-K 18 Feb 2020
2016 $3.32B -$69M -2.04% 01 Jan 2016 31 Dec 2016 8-K 08 Aug 2019
2015 $3.39B +$353M +11.6% 01 Jan 2015 31 Dec 2015 10-K 14 Feb 2018
2014 $3.03B +$105M +3.59% 01 Jan 2014 31 Dec 2014 10-K 09 Feb 2017
2013 $2.93B +$492M +20.2% 01 Jan 2013 31 Dec 2013 10-K 09 Feb 2016
2012 $2.44B +$178M +7.88% 01 Jan 2012 31 Dec 2012 10-K 10 Feb 2015
2011 $2.26B +$79M +3.63% 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014
2010 $2.18B 01 Jan 2010 31 Dec 2010 10-K 15 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.